Occurrence of the main metabolites of pharmaceuticals and personal care products in sludge stabilization treatments.

In Europe, approximately 40% of sludge yearly produced in wastewater treatment plants (WWTPs) is applied in agricultural lands as organic amendment, especially in arid regions. Sludge tends to concentrate wastewater pollutants. Many of them are not removed by sludge stabilization treatments and, as a result, they could originate adverse effects on soils, vegetation, animals, and humans. Although sludge stabilization treatments play an important role in removal contaminants from sludge and, therefore, in preventing contaminant discharges onto soils, there is scarce information about the occurrence of these compounds in these treatments. This fact is especially acute for emerging pollutants and, particularly, their metabolites. In this work, seven pharmaceuticals and personal care products, and their main metabolites, have been monitored in five different stabilization treatments: anaerobic and aerobic digestion, dehydration, composting, and lagooning. Sixteen compounds were measured in the analysed samples. Their distribution was similar in primary sludge, in spite of the different geographic locations of the WWTPs, The distribution was in accordance with the metabolic ratios of most of the studied compounds. Different behaviour was observed depending on the compound, for example, CBZ, 3-OH-CBZ, DIC, and 4-OH-DIC were highly persistent in all studied stabilization technologies whereas CAF, PX showed high degradability. Most of the studied compounds were measured in the final product of the sludge stabilization processes evaluated. This fact shows the necessity to improve the knowledge about the presence of these compounds in sludge intended to be applied onto soil and about the potential ecotoxicological risks of these compounds.